Table 5.
Haplotype frequency of RPSA polymorphisms in controls and sporadic CJD patients
| Haplotype | Controls (n = 50) |
Sporadic CJDs (n = 50) |
P-value |
|---|---|---|---|
| TCGT | 67.0% | 68.9% | - |
| CTAC | 18.0% | 19.0% | 0.943 |
| TCGC | 9.0% | 6.1% | 0.574 |
| CCGC | 5.0% | 4.9% | 0.714 |
| CTGT | 1.0% | 1.1% | 0.983 |